Feasibility of Total Gastrectomy with D2 Lymphadenectomy for Gastric Cancer and Predictive Factors for Its Short- and Long-Term Outcomes

Journal of Gastrointestinal Surgery

Volumn 20, Issue 3, 2016, Pages 521-530

  Chen, Fan Feng ^a   Huang, Dong Dong ^a   Lu, Jin Xiao ^a   Zhou, Chong Jun ^a   Zhuang, Cheng Le ^a   Wang, Su Lin ^a   Shen, Xian ^a   Yu, Zhen ^a,b   Chen, Xiao Lei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

D2 lymphadenectomy; Morbidity; Mortality; Survival; Total gastrectomy

Indexed keywords

AGED; CANCER STAGING; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEASIBILITY STUDY; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK FACTOR; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME;

AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84958154352     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-015-3059-x     Document Type: Article

References (43)

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65(2):87-108.
2. Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013; 132(5):1133-1145.
3. Kim JP. Current status of surgical treatment of gastric cancer. J Surg Oncol. 2002; 79(2):79-80.
4. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011; 14(2):113-123.
5. Bozzetti F, Marubini E, Bonfanti G, et al. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg. 1997; 226(5):613-620.
6. Gockel I, Pietzka S, Gonner U, et al. Subtotal or total gastrectomy for gastric cancer: impact of the surgical procedure on morbidity and prognosis--analysis of a 10-year experience. Langenbecks Arch Surg. 2005; 390(2):148-155.
7. Galizia G, Lieto E, De Vita F, et al. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis. Surgery. 2015; 157(2):285-296.
8. Japanese Gastric Cancer Association. Guidelines for diagnosis and treatment of carcinoma of the stomach. April 2004 edition. Available from: http://www.jgca.jp/pdf/Guidelines2004_eng.pdf.
9. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009; 250(2):187-196.
10. Bartlett EK, Roses RE, Kelz RR, et al. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database. Surgery. 2014; 156(2):298-304.
11. Watanabe M, Miyata H, Gotoh M, et al. Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg. 2014; 260(6):1034-1039.
12. Grossmann EM, Longo WE, Virgo KS, et al. Morbidity and mortality of gastrectomy for cancer in Department of Veterans Affairs Medical Centers. Surgery. 2002; 131(5):484-490.
13. Songun I, Putter H, Kranenbarg EM, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010; 11(5):439-449.
14. Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004; 22(11):2069-2077.
15. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999; 79(9-10):1522-1530.
16. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999; 340(12):908-914.
17. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996; 347(9007):995-999.
18. Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003; 349(22):2117-2127.
19. Chowdhury MM, Dagash H and Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg. 2007; 94(2):145-161.
20. Finlayson EV, Goodney PP and Birkmeyer JD. Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg. 2003; 138(7):721-725.
21. Damhuis RA, Wijnhoven BP, Plaisier PW, et al. Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types. Br J Surg. 2012; 99(8):1149-1154.
22. Tran TB, Worhunsky DJ, Norton JA, et al. Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative. Ann Surg Oncol. 2015.
23. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg. 1997; 84(11):1567-1571.
24. Hsu JT, Liu MS, Wang F, et al. Standard radical gastrectomy in octogenarians and nonagenarians with gastric cancer: are short-term surgical results and long-term survival substantial? J Gastrointest Surg. 2012; 16(4):728-737.
25. Mikami J, Kurokawa Y, Miyazaki Y, et al. Postoperative gastrectomy outcomes in octogenarians with gastric cancer. Surg Today. 2015; 45(9):1134-1138.
26. Seo SH, Hur H, An CW, et al. Operative risk factors in gastric cancer surgery for elderly patients. J Gastric Cancer. 2011; 11(2):116-121.
27. Shin HS, Oh SJ and Suh BJ. Factors related to morbidity in elderly gastric cancer patients undergoing gastrectomies. J Gastric Cancer. 2014; 14(3):173-179.
28. Wu CW, Lo SS, Shen KH, et al. Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J Surg. 2000; 24(4):465-472.
29. Bozzetti F, Ravera E, Cozzaglio L, et al. Comparison of nutritional status after total or subtotal gastrectomy. Nutrition. 1990; 6(5):371-375.
30. Kim AR, Cho J, Hsu YJ, et al. Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg. 2012; 256(6):1008-1013.
31. Cunningham SC, Kamangar F, Kim MP, et al. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg. 2005; 9(5):718-725.
32. Mickevicius A, Ignatavicius P, Markelis R, et al. Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study. BMC Surg. 2014; 14:98.
33. Wang J, Sun Y and Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Ann Surg Oncol. 2015; 22(9):2965-2971.
34. Kim HH, Han SU, Kim MC, et al. Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. J Clin Oncol. 2014; 32(7):627-633.
35. Kimura A, Ogata K, Kogure N, et al. Outcome of laparoscopic gastrectomy with D1 plus lymph node dissection in gastric cancer patients postoperatively diagnosed with locally advanced disease or lymph node metastasis. Surg Endosc. 2015.
36. Park do J, Han SU, Hyung WJ, et al. Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study. Surg Endosc. 2012; 26(6):1548-1553.
37. Park HJ, Ahn JY, Jung HY, et al. Clinical characteristics and outcomes for gastric cancer patients aged 18-30 years. Gastric Cancer. 2014; 17(4):649-660.
38. Lai CC, You JF, Yeh CY, et al. Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2011; 26(4):473-481.
39. Qiu M, Zhou YX, Jin Y, et al. Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy. Support Care Cancer. 2015; 23(7):1933-1939.
40. Shen Z, Ye Y, Xie Q, et al. Effect of the number of lymph nodes harvested on the long-term survival of gastric cancer patients according to tumor stage and location: a 12-year study of 1,637 cases. Am J Surg. 2015.
41. Kim JH, Chin HM and Jun KH. Surgical outcomes and survival after gastrectomy in octogenarians with gastric cancer. J Surg Res. 2015; 198(1):80-86.
42. Mortensen K, Nilsson M, Slim K, et al. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS(R)) Society recommendations. Br J Surg. 2014; 101(10):1209-1229.
43. Hur H, Song KY, Park CH, et al. Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea. Ann Surg Oncol. 2010; 17(1):54-64.